Clinical trials
Fever clinical trials
Below are recruiting fever clinical trials, each written for real people, not researchers. We’re tracking 80 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04270786Recruiting
De-escalating antibiotics early for neutropenic fever
This study looks at whether doctors can safely use fewer/less intense antibiotics after fever improves in adults with low white blood cell counts after a stem cell transplant. It may help reduce unnecessary antibiotic exposure while still treating serious infections.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT07286370RecruitingPhase 2
Vaccine study for typhoid and salmonella in infants
This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.
BanjulAges 1 month–6 months - NCT07278700Recruiting
Fever and respiratory infection study
This study looks at adults with a fever caused by a respiratory infection. If you qualify, you will have a blood draw as part of your regular care, and researchers will use it to learn more about your condition.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07231770Recruiting
Sulfamethoxazole prevention study after kidney transplant
This trial tests how long kidney transplant patients should take a common antibiotic (sulfamethoxazole) to prevent a lung infection called PJP. You may join if you are between 18 and 70 and have had a kidney transplant.
Hefei, AnhuiAges 18 years+ - NCT06207942Recruiting
Extended follow-up for cardiac arrest survivors and caregivers
This study follows up on survivors of out-of-hospital cardiac arrest who were already in the STEPCARE trial. It also looks at the well-being of their main caregiver (like a family member or close friend) to see how everyone is doing over time.
BrisbaneAges 18 years+ - NCT07172100Enrolling by invitationPhase 2
Papaya Leaf Extract for Kids with Dengue and Low Platelets
This trial tests if papaya leaf extract can help raise low platelet counts in young children with dengue fever. It may offer a natural way to reduce the risk of bleeding.
KarachiAges 2–12 - NCT07158814RecruitingPhase 4
Testing the safety of an RSV antibody in infants
This study checks if it is safe to delay the RSV preventive antibody shot by up to two weeks in infants who are getting their routine vaccines. Your baby will get the antibody at a second visit.
Oakland, CaliforniaAges 1 month–7 months - NCT07129538Recruiting
Breathing exercise for teens with FMF
This trial tests whether a special breathing exercise can help teens with FMF breathe better and feel stronger. It is for adolescents aged 13 to 17 who have FMF and are otherwise healthy.
Giza, DokkiAges 13–17 - NCT07074912Recruiting
Prescription fever medicine to reduce ER return visits
This study tests whether giving a prescription for fever-reducing medicine (like Tylenol or ibuprofen) when children leave the emergency room helps prevent them from having to return to the ER for fever. If your child is being sent home with a fever, this study wants to see if having the medicine on hand makes a difference.
Austin, TexasAges 6 months–3 years - NCT07051525Recruiting
Early vs. late stopping of antibiotics for fever in blood cancer treatment
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
Melbourne, VictoriaAges 18 years+ - NCT07004751Recruiting
Finding the cause of fever in Nepal
This study is trying to find the cause of fevers that last from 3 to 21 days in people who are admitted to the hospital. It may help doctors better understand and treat fevers in Nepal.
Lalitpur, BagmatiAges 16 years+ - NCT07000747Recruiting
Dengue and sickle cell disease study
This study looks at how severe dengue fever affects people with sickle cell disease. It aims to understand why some people with sickle cell get very sick from dengue and how their cells react.
Pointe-à-PitreAges 6–25 - NCT06539325Recruiting
Rapid testing for fever after travel to the tropics
This trial uses a rapid test to find the cause of fever in people who recently returned from tropical areas. It aims to detect new or unusual infections early, when you are still in the emergency department.
Paris, ParisAges 18–99 - NCT06338891Recruiting
Can gluten or wheat trigger FMF attacks?
This trial looks at whether foods like gluten or wheat might cause attacks in people with Familial Mediterranean Fever (FMF). If you have FMF, joining could help understand if changing your diet can prevent attacks.
Palermo, SicilyAges 6 months–80 years - NCT06917001RecruitingPhase 2
Testing Resomelagon for dengue fever
This trial tests whether a new medicine called Resomelagon can safely treat dengue fever. It looks at how well the medicine works and if it helps you recover faster.
Belo Horizonte, Minas GeraisAges 18–65 - NCT06259006RecruitingPhase 3
Early Dexamethasone for Sydenham's Chorea in Children
This trial tests whether a short course of dexamethasone (a steroid tablet) can help children with Sydenham's chorea (movement tics after a strep infection) recover faster. The goal is to see if early treatment improves symptoms and reduces side effects compared to other treatments.
Darwin, Northern TerritoriesAges 4–17 - NCT06336733RecruitingPhase 3
Trial of anakinra for FMF attacks in patients who refuse daily shots
This trial tests if taking anakinra (a targeted medicine) only when you have a painful FMF attack can help, instead of taking it every day. It is for people with Familial Mediterranean Fever (FMF) whose attacks continue despite taking colchicine, and who do not want daily injections.
ParisAges 6 years+ - NCT06910631Recruiting
Using a finger-prick test to guide fever care in children
This study tests whether a quick finger-prick test that measures C-reactive protein (CRP) can help doctors decide when a feverish child needs antibiotics or further care. It aims to improve how fever is managed in primary care settings.
AgdeAges 3 months–15 years - NCT06718127Recruiting
Study of immune response to yellow fever vaccine
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
ParisAges 18–65 - NCT06860334RecruitingPhase 2
Testing treatments for Crimean-Congo hemorrhagic fever
This trial tests different treatments for Crimean-Congo hemorrhagic fever (CCHF), a serious viral infection. It aims to find which treatment is safe and works best for patients who are hospitalized with the disease.
ErzurumAges 18 years+ - NCT06843226Recruiting
Dengue vaccine study for children and teens
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
Banjarmasin, South KalimantanAges 6–12 - NCT06805214Recruiting
Body temperature after tracheostomy: a study
This study looks at whether body temperature changes after a tracheostomy, a surgery that creates a hole in the neck to help with breathing. The goal is to help doctors better understand what is normal after this procedure.
Kfar SabaAges 18–99 - NCT06665035RecruitingPhase 3
Dengue vaccine study for infants and toddlers
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
Barranquilla, AtlánticoAges 6 months–1.7 years - NCT06618989Recruiting
Predicting serious bacterial infection in febrile infants
This trial is testing a new blood test to help doctors tell which babies under three months with fever are at risk for a serious bacterial infection. If successful, it could help avoid unnecessary antibiotics and hospital stays.
Paris, FranceAges 1 week–3 months
Hear when a new Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for fever?
- Yes. Clin2 currently lists 80 recruiting fever studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a fever trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a fever trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.